Overview
Arbitrum (ARB) and Injective (INJ) sit at different layers of the crypto stack. At current prices ($0.081300 vs $5.08), market leadership still favors Arbitrum on capitalization, while 24h tape is led by Injective.
Quick winners
Full comparison
| Metric | ARB | INJ |
|---|---|---|
| Price | $0.081300 | $5.08 |
| Market Cap | $543.44M | $490.41M |
| FDV | — | — |
| Volume 24h | $4.58M | $2.27M |
| Circulating Supply | — | — |
| Total Supply | — | — |
| Max Supply | — | — |
| Rank | 95.00 | 99.00 |
| Dominance | — | — |
| Liquidity | — | — |
| Volatility | +5.47% | +5.97% |
| ATH | — | — |
| ATL | — | — |
| ROI | — | — |
Performance
| Timeframe | ARB | INJ |
|---|---|---|
| 1H | — | — |
| 24H | +3.83% | +4.65% |
| 7D | — | — |
| 30D | — | — |
| 90D | — | — |
| 1Y | — | — |
| YTD | — | — |
| ALL | — | — |
Comparative chart
Technical indicators
| Indicator | ARB | INJ |
|---|---|---|
| RSI | 42.16 | 49.29 |
| MACD histogram | — | — |
| EMA20 | — | — |
| EMA50 | — | — |
| EMA100 | — | — |
| EMA200 | — | — |
| SMA50 | — | — |
| SMA200 | — | — |
| ATR | 0.00 | 0.29 |
| ADX | 22.88 | 12.19 |
| Support | 0.08 | 4.91 |
| Resistance | 0.09 | 5.47 |
| Trend | bearish | neutral |
| Momentum | — | — |
| Signal | neutral | neutral |
Automatic technical analysis
Automated technical notes for this pair highlight bearish conditions on ARB and neutral on INJ. Volatility differences can amplify short-term gaps.
Fundamentals
| Metric | ARB | INJ |
|---|---|---|
| Consensus | — | — |
| Blockchain | — | — |
| TPS | — | — |
| Block time | — | — |
| Finality | — | — |
| Validators | — | — |
| Staking | — | — |
| TVL | — | — |
| Supply model | — | — |
| Inflation | — | — |
| Developer activity | 4.00 | 0.00 |
| Github activity | 101.00 | 118.00 |
| On-chain activity | — | — |
| Whale activity | — | — |
| Addresses | — | — |
| Gas fees | — | — |
Ecosystem
Arbitrum
Injective
Pros and cons
Pros of Arbitrum
- Higher ranking for Arbitrum can translate into tighter spreads on major venues.
- Composite PEPS readings for Arbitrum can surface clearer module agreement during trend phases.
- Arbitrum typically benefits from deeper liquidity and broader market recognition inside the Top 300 set.
Cons of Arbitrum
- Large-cap status for Arbitrum can mean slower percentage upside versus high-beta alternatives.
- When dominance narratives fade, Arbitrum can lag hotter rotation names.
- Data gaps in niche fundamentals still apply — absence of a field is not confirmation.
- Regulatory or macro headlines can hit Arbitrum harder simply because it is more visible.
Pros of Injective
- Active volume bursts on INJ sometimes precede sharper tactical moves.
- Diversifying versus Arbitrum with Injective can change portfolio factor exposure.
- PEPS tracking for Injective still includes AI score and level context for monitoring.
Cons of Injective
- Smaller book depth versus large caps can increase slippage for Injective.
- Weaker market-cap standing may leave Injective more exposed to liquidity droughts.
- Higher volatility on INJ cuts both ways and demands stricter risk limits.
Which looks stronger right now?
Across winners above, no single coin dominates every column. Prefer scenarios: trend continuation favors the side with aligned momentum; mean-reversion favors the side stretched on RSI.
AI summary
PEPS synthesizes module output into a readable pair brief. Headline stats put Arbitrum at $0.081300 and Injective at $5.08. Relative performance over 24h (Injective) is a short window. Pair it with 30d/1y rows before inferring regime change. Return to related comparisons and individual coin intelligence pages to validate whether the relative story still holds after fresh prints.
FAQ
Which is better, Arbitrum or Injective?
“Better” depends on horizon and risk. Arbitrum leads on market cap today, while Injective leads the 24h move — neither is a guarantee.
Which has more upside potential, ARB or INJ?
Higher-beta assets can move more in both directions. Use performance tables and volatility, not headlines, to judge potential ranges.
Which is less risky right now?
Lower volatility and deeper liquidity usually imply milder path risk, but crypto tails remain large for both Arbitrum and Injective.
Which has stronger developer activity?
Check the fundamentals table for developer/github fields when populated. Missing values mean the feed has no reliable reading yet.
Which looks more decentralized?
Decentralization is multi-dimensional (validators, client diversity, token distribution). This page surfaces available consensus/validator fields without over-claiming.
Which has lower fees?
Fee comparisons belong to each network’s fee market. Where gas/fee metrics exist in fundamentals, compare them; otherwise verify on explorers.
Which is better for investing?
Investing choices need personal constraints. Use this comparison as research input, then size positions with an explicit invalidation plan.
Which is better for staking?
If staking fields are present, compare yield mechanics and lockups off-platform. Staking returns are not risk-free.
Which is more used day to day?
Volume, on-chain activity and ecosystem links are practical usage proxies. Arbitrum currently leads traded volume on this snapshot.
Which has the better recent performance?
See the performance table across 1h through 1y. The 24h leader is Injective, but longer windows can disagree.